CDNA - CareDxAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $31.23 | Open | $31.08 |
| Volume | 292.3K | Market Cap | 1.634B |
| Yield | Last Dividend |
| Hedge Funds Aren???t Crazy About CareDx,... | 06/24/20 |
| The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that sho... | |
| Seven Bridges Selected by CareDx to Adva... | 06/09/20 |
| Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting t... | |
| CareDx to Participate at the Goldman Sac... | 06/04/20 |
| SOUTH SAN FRANCISCO, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the??? | |
| CareDx and Veracyte Announce Exclusive P... | 05/14/20 |
| CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System | |
| CareDx (CDNA) Reports Break-Even Earning... | 04/30/20 |
| CareDx (CDNA) delivered earnings and revenue surprises of -100.00% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clue... | |
| Earnings Preview: CareDx (CDNA) Q1 Earni... | 04/23/20 |
| CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with th... | |
| CareDx CEO Says Pandemic Proves Value Of... | 04/21/20 |
| One outcome from the coronavirus pandemic could be the adoption of CareDx Inc (NASDAQ: CDNA )???s management platform for organ transplant patients. ?... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| CareDx (CDNA) Earnings Expected to Grow:... | 02/20/20 |
| CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with th... | |
| CareDx (CDNA) Upgraded to Strong Buy: He... | 02/07/20 |
| CareDx (CDNA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive t... | |
| When Will CareDx, Inc (NASDAQ:CDNA) Brea... | 01/22/20 |
| CareDx, Inc's (NASDAQ:CDNA): CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on??? | |
| CareDx's AlloSeq cfDNA Awarded CE Mark A... | 01/10/20 |
| SOUTH SAN FRANCISCO, Calif., Jan. 10, 2020 -- CareDx, Inc. , a leading precision medicine company focused on the discovery, development and commercial... | |
| Is CareDx, Inc. (CDNA) A Good Stock To B... | 12/07/19 |
| With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world pr... | |
| The Daily Biotech Pulse: Roche-Spark Dea... | 11/22/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.... | |
| All You Need to Know About CareDx (CDNA)... | 11/01/19 |
| CareDx (CDNA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive t... | |
| Were Hedge Funds Right About Flocking In... | 10/26/19 |
| Is CareDx, Inc. (NASDAQ:CDNA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by s... | |
| We're Excited To See How CareDx (NASDAQ:... | 10/12/19 |
| There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although??? | |
| CareDx, Inc (CDNA) Shares March Higher, ... | 10/07/19 |
| As of late, it has definitely been a great time to be an investor in CareDx, Inc (CDNA). | |
| Is CareDx, Inc's (NASDAQ:CDNA) CEO Salar... | 08/05/19 |
| Peter Maag became the CEO of CareDx, Inc (NASDAQ:CDNA) in 2012. This report will, first, examine the CEO compensation??? | |
| CareDx (CDNA) Reports Next Week: Wall St... | 07/25/19 |
| CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with th... | |
| CareDx Inc. looks like it can continue i... | 07/11/19 |
| CareDx Inc. (CDNA) looks like it can continue its impressive rally as all the charts of the molecular diagnostic company appear bullish, so go long it... | |
| The Daily Biotech Pulse: DiaMedica Repor... | 06/20/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) ... | |
| Dermavant Sciences Appoints Timothy S. N... | 05/15/19 |
| LONDON, May 15, 2019 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that Timothy S. Nel... | |
| Here's Why CareDx Stock Is Rising Today | 05/09/19 |
| The transplant diagnostic service provider took some important steps forward in the first quarter. | |
| CareDx, Inc. (CDNA) CEO Peter Maag on Q1... | 05/08/19 |
| No summary available. | |
| CareDx, Inc (CDNA) Q1 2019 Earnings Call... | 05/08/19 |
| CDNA earnings call for the period ending March 31, 2019. | |
| CareDx (CDNA) Q1 Earnings and Revenues T... | 05/08/19 |
| CareDx (CDNA) delivered earnings and revenue surprises of 350.00% and 7.07%, respectively, for the quarter ended March 2019. Do the numbers hold clues... | |
| ROKU, INFN, FOSL and STMP among notable ... | 05/08/19 |
| No summary available. | |
| CareDx, Inc beats by $0.09, beats on rev... | 05/08/19 |
| No summary available. | |
| Buy rating | 08/05/20 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $37.00 to $40.00 | |
| rating | 08/05/20 |
| Raymond James maintains Strong Buy rating and raises Price Target from $40.00 to $42.00 | |
| Buy rating | 06/26/20 |
| BTIG initiates coverage with Buy rating and announces Price Target of $40.00 | |
| Buy rating | 06/19/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $40.00 to $37.00 | |
| Date | 2020-08-04 (AMC) | Est. (EPS/Rev.) | ($0.04)/ 35.61M |
| Actual (EPS/Rev.) | $0.04/ $41.80 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swingers Corner | Akemi Mokoto | 42.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
